BB
REGN icon

Busey Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Busey Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$643K Sell
1,031
-23
-2% -$15.7K 0.02% 228
2026
Q1 		$814K Sell
1,054
-106
-9% -$81.2K 0.02% 199
2025
Q4 		$895K Sell
1,160
-34
-3% -$23.1K 0.02% 189
2025
Q3 		$671K Sell
1,194
-144
-11% -$81.4K 0.02% 213
2025
Q2 		$702K Sell
1,338
-113
-8% -$63.1K 0.02% 209
2025
Q1 		$920K Sell
1,451
-39
-3% -$26.8K 0.03% 174
2024
Q4 		$1.06M Sell
1,490
-73
-5% -$61.3K 0.03% 167
2024
Q3 		$1.64M Sell
1,563
-227
-13% -$253K 0.05% 147
2024
Q2 		$1.88M Sell
1,790
-92
-5% -$89.2K 0.06% 139
2024
Q1 		$1.81M Sell
1,882
-115
-6% -$109K 0.06% 142
2023
Q4 		$1.75M Buy
1,997
+16
+0.8% +$13.2K 0.07% 141
2023
Q3 		$1.63M Sell
1,981
-319
-14% -$251K 0.07% 136
2023
Q2 		$1.65M Sell
2,300
-52
-2% -$40.1K 0.07% 140
2023
Q1 		$1.93M Sell
2,352
-67
-3% -$50.5K 0.08% 134
2022
Q4 		$1.75M Sell
2,419
-33
-1% -$24.3K 0.08% 140
2022
Q3 		$1.69M Sell
2,452
-137
-5% -$86.2K 0.08% 139
2022
Q2 		$1.53M Sell
2,589
-387
-13% -$252K 0.07% 151
2022
Q1 		$2.08M Sell
2,976
-35
-1% -$22.1K 0.08% 148
2021
Q4 		$1.9M Sell
3,011
-129
-4% -$79.3K 0.07% 157
2021
Q3 		$1.9M Sell
3,140
-332
-10% -$206K 0.08% 149
2021
Q2 		$1.94M Sell
3,472
-139
-4% -$70.4K 0.09% 135
2021
Q1 		$1.71M Sell
3,611
-245
-6% -$119K 0.09% 139
2020
Q4 		$1.86M Sell
3,856
-160
-4% -$86.4K 0.11% 132
2020
Q3 		$2.25M Sell
4,016
-64
-2% -$38.8K 0.14% 118
2020
Q2 		$2.54M Sell
4,080
-69
-2% -$39.2K 0.18% 109
2020
Q1 		$2.02M Sell
4,149
-19
-0.5% -$7.84K 0.16% 115
2019
Q4 		$1.56M Sell
4,168
-735
-15% -$247K 0.1% 146
2019
Q3 		$1.36M Buy
+4,903
New +$1.45M 0.1% 149

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Busey Bank's REGN Position: Q2 2026 in Review

Busey Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 2.2% in Q2 2026, selling an estimated $15.7K and leaving 1,031 shares worth $643K. The position accounts for 0.02% of the portfolio, ranked #228.

Busey Bank first reported a position in REGN in Q3 2019 and has held it in 28 quarters since. The position peaked at $2.54M in Q2 2020. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Busey Bank held 1,031 shares of Regeneron Pharmaceuticals worth $643K as of Q2 2026.
  • Busey Bank sold 23 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $15.7K.
  • Regeneron Pharmaceuticals made up 0.02% of Busey Bank's portfolio in Q2 2026, its #228 holding.
  • Busey Bank first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
  • Busey Bank's Regeneron Pharmaceuticals position peaked at $2.54M in Q2 2020.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Busey Bank's 13F filing for Q2 2026, filed 13 Aug 2026.